Notably, Dermcidin (DCD) and prolactin inducible protein (PIP) serve as biomarkers, with DCD linked to breast cancer and lymph nodes, while PIP is overexpressed in breast and prostate cancer [37]. Here, PIP is linked to prostate carcinoma.